APIs
Product Description
Samyang Holdings Corporation
-
Country/Region:Korea, Republic Of
-
On CPHI since:2022
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
Categories
Samyang Holdings Corporation
-
Country/Region:Korea, Republic Of
-
On CPHI since:2022
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
More Products from Samyang Holdings Corporation (2)
-
Product FPFs
• Genexol®PM Inj.(Paclitaxel) • Genexol® Inj.(Paclitaxel) • Nanoxel®M Inj.(Docetaxel) • Docetaxel Inj.(Docetaxel) • Nexatin® Inj.(Oxaliplatin) • Everose® Tab.(Everolimus) • Pemed®S Inj.(Pemetrexed) • Azalid® Inj.(Azacitidine) • Decilid® Inj.(Decitabine) • Lenalid® Inj.(Lenalid... -
Product CDMO
• Cytotoxic Injection (Liquid , Lyophilized) • ONCOLOGY • CYTOTOXIC API • EU GMP • JGMP (Japan) • KGMP (Korea) • PIC/S
Samyang Holdings Corporation resources (1)
-
Brochure Samyang Holdings Corporation_Brochure
Product portfolio

